ArticleCancer immunology, immunotherapy : CII2015

Evaluation of serum osteopontin level and gene polymorphism as biomarkers: analyses from the Nordic Adjuvant Interferon alpha Melanoma trial.

Lina Prasmickaite et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.